NVCR - Novocure Ltd logo

NVCR

Novocure Ltd

Novocure Ltd develops and commercializes tumor treating fields (TTFields) devices for solid tumor cancers. Its products include Optune Gio, Optune Lua, and Optune Pax, targeting conditions like glioblastoma and malignant pleural mesothelioma.

โš•๏ธ Healthcare NASDAQ Listed 2015 $ USD
$1,000 invested 10 years ago โ†’$2,227today

Score Overview

1 Year
Score
Net Growth-9.06%
Net TrendShrank
Net Income Consistencyโ€”
Rev Growth6.69%
Rev TrendGrew
Revenue Consistencyโ€”
5 Years
Score3.8
Net Growth-154.61%
Net Trend40%
Net Income Consistencyโ€”
Rev Growth30.68%
Rev Trend80%
Revenue Consistencyโ€”
10 Years
Score
Net Growth-12.68%
Net Trend50%
Net Income Consistency
Rev Growth8x
Rev Trend90%
Revenue Consistency
All Time
Score
Net Growth-33.15%
Net Trend45%
Net Income Consistency
Rev Growth21x
Rev Trend91%
Revenue Consistency

See the full market ranking โ†’

Novocure Ltd fundamental performance

Between 2020 and 2025, revenue grew from $ 494M to $ 655M and net income went from $ 19M to -$ 136M. Revenue increased in 4 of those 5 years; net income in 2.

Between 2015 and 2025, revenue grew from $ 33M to $ 655M and net income went from -$ 111M to -$ 136M. Revenue increased in 9 of those 10 years; net income in 5.

Novocure Ltd currently holds a 5-year HDB Score of 3.8 out of 10. How the HDB Score is calculated.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-12
$ 17.59โ€”
1 Year2025-08-12
$ 11.3455.11%
5 Years2021-08-12
$ 142.00-87.61%
10 Years2016-08-12
$ 7.90122.66%
All Time2015-10-02
$ 18.28-3.77%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 699M-$ 148M$ 440M
2025$ 655M-$ 136M$ 457M
2024$ 605M-$ 168M$ 959M
2023$ 509M-$ 207M$ 910M
2022$ 537M-$ 92M$ 969M
2021$ 535M-$ 58M$ 937M
2020$ 494M$ 19M$ 854M
2019$ 351M-$ 7M$ 326M
2018$ 248M-$ 63M$ 245M
2017$ 177M-$ 61M$ 183M
2016$ 82M-$ 131M$ 219M
IPO2015$ 33M-$ 111M$ 269M

Explore beyond NVCR

You're looking at Novocure Ltd. Members apply the same fundamental framework across all 3,860 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies